Markus Warmuth und Biomedicine - Info zur Person

(1 - 23 von 25

)

EISAI'S U.S. RESEARCH SUBSIDIARY H3 BIOMEDICINE ENTERS INTO...

www.eisai.com

Eisai's news release EISAI'S U.S. RESEARCH SUBSIDIARY H3 BIOMEDICINE ENTERS INTO COLLABORATIVE AGREEMENT WITH SELVITA TO CREATE NOVEL ANTICANCER AGENTS is...

H3 Biomedicine to Present Outlook at the 36th Annual J.P. Morgan...

www.marketscreener.com

Company highlights focus on driving forward three differentiated, internally generated cancer therapies to clinical proof of concept

H3 Biomedicine Names Markus Warmuth Chief Executive Officer |...

www.businesswire.com

H3 Biomedicine Names Markus Warmuth Chief Executive Officer

H3 Biomedicine Names Markus Warmuth Chief Executive Officerwww.businesswire.com › news › home › H3-Biome...

www.businesswire.com

· Markus Warmuth, M.D. is new Chief Executive Officer of Cambridge-based H3 Biomedicine. H3 is a unique oncology drug discovery company ...

Loss of function JAK1 mutations occur at high frequency in cancers ...journals.plos.org › plosone › article › authors › jour...

journals.plos.org

· Markus Warmuth. Affiliation H3 Biomedicine, Cambridge, Massachusetts, United States of America. Philip J. Stephens.

Discovery of Selective Estrogen Receptor Covalent Antagonists for ...aacrjournals.org › cancerdiscovery › article-abstract

aacrjournals.org

Markus Warmuth;. Markus Warmuth. 1H3 Biomedicine, Inc., Cambridge, Massachusetts. Search for other works by this author on:.

Markus Warmuth Net Worth (2020) | wallminede.wallmine.com › imv › officer

de.wallmine.com

Dr. Markus Warmuth is Director of the Company. Prior to his role at Third Rock, Dr. Warmuth spent seven years as the Chief Executive Officer of H3 Biomedicine, ...

H3 Biomedicine- Health, Hope and Heaps of Japanese Fundingwww.bio-itworld.com › issues › jan › H3-biomedici...

www.bio-itworld.com

· Joining president and CEO Markus Warmuth were dignitaries from Massachusetts state and local government, as well as Haruo Naito, ...

Foundation Medicine and H3 Biomedicine Announce Collaboration ...www.foundationmedicine.com › press-releases

www.foundationmedicine.com

"Large-scale genomic data sets are the key to identifying actionable targets and addressing the multitude of difficult-to-treat cancers," said Markus Warmuth , ...

Eisai Newsroom - Press Releases

eisai.mediaroom.com

In October 2011, Markus Warmuth, M.D., was appointed as President and CEO of H3 Biomedicine. Dr. Warmuth brings with him industrial experience in analytical ... › pres...

H3 Biomedicine Publishes Comprehensive Genomic Landscape Analysis in...

www.h3biomedicine.com

... promoting tumor formation and progression,” said Markus Warmuth, M.D., President and Chief Executive Officer of H3 Biomedicine Inc. “This ...

Loss of function JAK1 mutations occur at high frequency in ...

journals.plos.org

von LA Albacker · · Zitiert von: 58 — Markus Warmuth,. Affiliation H3 Biomedicine, Cambridge, Massachusetts, United States of America. ⨯. Philip J. Stephens,. › article › j...

H3 Biomedicine marks the opening of its Kendall Square office - The...

www.bostonglobe.com

H3 Biomedicine Inc., a start-up focused on cancer treatments based on genetics, is officially unveiling its new 24,000-square-foot office in Cambridge today,...

H3 Biomedicine Expands Cambridge, MA Facilities | Business ...businessfacilities.com › ... › Biotech & Pharma

businessfacilities.com

· Markus Warmuth, M.D., President and Chief Executive Officer of H3 Biomedicine. “Our unique corporate culture encourages science driven ...

H3 Biomedicine to Present Early-Stage Cancer Research at the

eisai.mediaroom.com

... drug candidate and validating our splicing modulation platform," said Markus Warmuth, M.D., President and CEO of H3 Biomedicine.

H3 Biomedicine and Selvita Extend Precision Cancer Medicines ...ryvu.com › › h3-biomedicine-and-selvit...

ryvu.com

· ... vision and mission,” said Markus Warmuth, president and chief executive officer of H3 Biomedicine. “The strength of the combined teams has ...

H3 Biomedicine’s Preclinical Data Highlighting Novel Discovery...

www.biospace.com

H3 Biomedicine’s Preclinical Data Highlighting Novel Discovery Research in Hepatocellular Carcinoma Published in December Issue of Cancer Research - read this...

Loss of function JAK1 mutations occur at high frequency in cancers...

journals.plos.org

· Affiliation H3 Biomedicine, Cambridge, Massachusetts, United States of America. ⨯. Markus Warmuth,. Affiliation H3 Biomedicine, Cambridge, ...

Cultivating a Drug Discovery Ecosystem - Mary Ann Liebert, Inc.www.liebertpub.com › doi › full › gen

www.liebertpub.com

· Markus Warmuth, M.D.. President and CEO. Number of Employees Focus. H3 Biomedicine develops targeted anticancer compounds based upon its ...

Foundation Medicine and H3 Biomedicine Announce Collaboration ...www.h3biomedicine.com › › foundatio...

www.h3biomedicine.com

· ... the multitude of difficult-to-treat cancers,” said Markus Warmuth, M.D., president and chief executive officer of H3 Biomedicine.

H3 Biomedicine's CEO Says Bioinformatics Plays 'Big Role' in ...www.genomeweb.com › ... › Informatics

www.genomeweb.com

· CEO Markus Warmuth told BioInform that bioinformatics plays a "big role" in the company's efforts to look through publicly available ...

H3 Biomedicine, Foundation Medicine extend collaboration on ...www.centerwatch.com › articles › h3-biome...

www.centerwatch.com

· ... the current oncology drug development market,” said Markus Warmuth, M.D., president and chief executive officer of H3 Biomedicine.

The Ticker - Boston Heraldwww.bostonherald.com › › the-ticker-2

www.bostonherald.com

· Cambridge's H3 Biomedicine Inc. has promoted Dr. Markus Warmuth, formerly head of oncology drug discovery for the nearby Novartis Institute ...

Alle Infos zum Namen "Markus Warmuth"

Verwandte Suchanfragen zu Markus Warmuth

Otmar Zorn
Bruno Meiser

Person "Warmuth" (5)
Vorname "Markus" (61377)
Name "Warmuth" (465)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Markus Warmuth und Biomedicine Person-Info